News
Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing
June 28, 2010 7:32 am | by Bio-Medicine.Org | CommentsCHENGDU, China , June 28 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical (NYSE Amex: TPI ), a biopharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine and branded generics will exhibit and promote its flagship product...
International study identifies 12 new genetic risk factors for type 2 diabetes
June 28, 2010 6:38 am | by EurekAlert | Comments(Helmholtz Zentrum München - German Research Center for Environmental Health) An international consortium including Helmholtz Zentrum Muenchen and the German Diabetes Center, Duesseldorf, has identified 12 new gene variants which impact the individual's risk of developing type 2...
Partners CIO Glaser heads to Siemens
June 28, 2010 6:38 am | by Mass High Tech: The Journal of New England Technology | CommentsSiemens Healthcare has hired away Partners Healthcare CIO John Glaser to head up its global healthcare IT business. The job change ends Glaser's tenure as CIO at Partners, which had lasted 15 years.
Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) to CNS Development Pipeline
June 28, 2010 6:37 am | by Bio-Medicine.Org | CommentsMAPLE GROVE, Minn. , June 28 /- Upsher-Smith Laboratories, Inc. today announced an agreement with Ikano Therapeutics, Inc. to obtain exclusive global rights to ITI-111, Ikano's nasal midazolam. Under terms of the agreement, Upsher-Smith will assume all further development, testing...
New Data Demonstrates Victoza® (liraglutide rDNA injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at On...
June 28, 2010 6:36 am | by Bio-Medicine.Org | CommentsORLANDO, Fla. , June 28 /- Poster 16LB -- Late-breaking Novo Nordisk (NVO) extension data presented today at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily Victoza ® in combination with metformin produced sustained and...
New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes
June 28, 2010 6:36 am | by Bio-Medicine.Org | CommentsPARSIPPANY, N.J. , June 28 /- Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a...
International child-health experts to converge on London for Excellence in Pediatrics
June 28, 2010 6:34 am | by EurekAlert | Comments(Wiley-Blackwell) Excellence in Pediatrics will provide an up-to-date and authoritative overview of pediatrics and child health through a variety of innovative sessions, designed for general and specialist health professionals. It will focus on four thematic streams: infectious...
New High-Resolution Computer Tomography Data Demonstrates EVISTA(R)'s Effect on Bone Quality in Osteoporotic Patients
June 28, 2010 1:33 am | by Bio-Medicine.Org | CommentsMUNICH , June 28, 2010 /- - 3D Images Provide New Approach to Monitoring Bone Changes Interim data from a prospective Investigator Initiated Trial (IIT) presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow , demonstrates that EVISTA(R) (raloxifene 60mg; once-d...
Combination MMRV Vaccine Associated with Two-Fold Risk of Febrile Seizures Compared with Separate MMR & Varicella Vaccines
June 27, 2010 10:35 pm | by Bio-Medicine.Org | CommentsOAKLAND, Calif. , June 28 /- The combination vaccine for measles, mumps, rubella and chickenpox (MMRV) is associated with double the risk of febrile seizures for 1- to 2-year-old children compared with same-day administration of the separate vaccine for MMR (measles, mumps, rubella) and...
Global Pharmaceutical R & D Productivity Declining According to Thomson Reuters, CMR International
June 27, 2010 10:35 pm | by Bio-Medicine.Org | CommentsPHILADELPHIA and LONDON , June 28 /- The pharmaceutical industry continues to rely heavily on sales from an aging portfolio of drugs, whilst the proportion of total sales from newer drugs has dropped, according to data released today from the 2010 Pharmaceutical R&D Factbook complied...
Researchers develop accurate way to predict the age when women will hit the menopause
June 27, 2010 8:40 pm | by EurekAlert | Comments(European Society of Human Reproduction and Embryology) Researchers have developed a way of accurately predicting when women will hit the menopause using a simple blood test. The average difference between the predicted age and the actual age that the women in their study reached...
Healthier cafeteria food, more intense gym classes lower students' diabetes risk
June 27, 2010 8:40 pm | by EurekAlert | Comments(University of California - Irvine) Healthier cafeteria choices, longer and more intense periods of physical activity and robust in-school education programs can lower rates of obesity and other risk factors for type 2 diabetes, according to a national study called HEALTHY.
Intervention lowered obesity rate in youth at high diabetes risk, HEALTHY study finds
June 27, 2010 8:40 pm | by EurekAlert | Comments(NIH/National Institute of Diabetes and Digestive and Kidney Diseases) An intervention in middle schools lowered the obesity rate in students at highest risk for type 2 diabetes, those who started out overweight or obese in sixth grade, an NIH-funded study has found. However,...
Building a Substitute Pancreas for Diabetics
June 27, 2010 8:38 pm | by Massachusetts Institute of Technology | CommentsA startup hopes implanted insulin-producing cells will free diabetics from insulin injections.
Statins associated with lower cancer recurrence following prostatectomy
June 27, 2010 8:34 pm | by EurekAlert | Comments(Duke University Medical Center) Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to researchers at Duke University Medical Center. Researchers also...
